ICN's U.S. suit hits Yugoslav, Serb leaders
Article Abstract:
United States-based ICN Pharmaceuticals Inc., has filed a lawsuit against Serbia and Yugoslav state governments for nationalising its subsidiary ICN Yugoslavia. ICN Pharmaceuticals seeks $500 million for the forcible acquisition.
Comment:
ICN Pharmaceutical Inc., sues Serbia and Yugoslav government for nationalizing its subsidiary ICN Yugoslavia.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Amgen plans to buy Immunex for $16 billion in cash, stock
Article Abstract:
Amgen Inc. has reached a deal to acquire Immunex Corp. in a deal valued at $16 billion. The deal, one of the largest biotechnology acquisitions ever, will be conducted in cash and shares.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Bristol-Myers nears pact to buy ImClone stake
Article Abstract:
Bristol-Myers Squibb Co. is close to a deal in which it will acquire a minority share in ImClone Systems Inc. Bristol-Myers will acquire 19.9% of ImClone for $1 billion.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Sex, swagger helped fallen Gucci recover its glamour. Apax nears deal to buy Hilfiger for $1.5 billion. Executives sell another affiliate to Tommy Hilfiger
- Abstracts: Danone's Polish unit recalls dessert. Poland to open license tender for phone service. Pawnshops are windows to Poland's pain
- Abstracts: Clutter control. A plan for all seasons. Click and save
- Abstracts: Attacks could boost telecommunications industry. Japan car shares downshift. Air-flight jitters may boost video-conferencing services
- Abstracts: Asean gets a lift from new leaders before summit. Japan's late play for Asean